Crossmark

Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study

Crossref DOI link: https://doi.org/10.1007/s00280-017-3471-x

Published Online: 2017-10-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Jong, Jan

Hellemans, Peter

Jiao, James Juhui

Huang, Yuhan

Mesens, Sofie

Sukbuntherng, Juthamas

Ouellet, Daniele
Funding

Funding for this research was provided by:

Janssen Research and Development

Pharmacyclics LLC, an Abb Vie company
License Information

License valid from 2017-10-28